Drug Discovery & Development

New Business

Ascletis Pharma trial shows drug candidate ASC47 boosts weight loss effect of semaglutide

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the popular anti-obesity…

Read More »
Back to top button